Study for Collection of Aflibercept Data in Routine Practice
Status:
Completed
Trial end date:
2017-11-27
Target enrollment:
Participant gender:
Summary
The French CODEX study is designed as a national database to describe, in routine medical
practice, functional and anatomical responses to intravitreal Aflibercept injection, in a
large population of anti-VGEF-naïve patients presenting with wet Age-related Macular
Degeneration (wAMD), Central Retinal Vein Occlusion (CRVO),Branch Retinal Vein
Occlusion(BRVO), or Diabetic Macular Edema (DME). This national database will gather
databases from French private and public ophthalmologic centers.